AI Article Synopsis
Article Abstract
The WAA (World Apheresis Association) registry for apheresis has been developed to enable registration through internet by centers all around the world. It is of no charge for the registering centers. The new version is available at the site www.iml.umu.se/medicin. Until now more than 5700 treatments have been registered from centers in 6 countries. It allows registration of acute or chronic therapeutic apheresis and also collection of stem cells, cellapheresis, photopheresis and various adsorption technologies. Registration includes diagnoses, access, anticoagulation, replacement fluids, mode of treatment, volumes processed, techniques used and adverse events that develop. Analyses of data enables improvement of quality of apheresis. The new registry enables you to change data that were wrongly entered as well as add data that was missed when you firstly entered the file. We cordially invite all of you to join the registration procedure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.transci.2005.12.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanisms of action of an investigational new freeze-dried platelet-derived hemostatic product.
J Thromb Haemost
March 2024
Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA.
Background: A safe and efficacious hemostatic product with a long shelf-life is needed to reduce mortality from hemorrhage due to trauma and improve surgical outcomes for persons with platelet deficiency or dysfunction. Thrombosomes, a trehalose-stabilized, leukoreduced, pooled blood group-O freeze-dried platelet-derived hemostatic (FPH) with a 3-year shelf-life, may satisfy this need.
Objectives: To characterize the mechanism of action of FPH.
The world apheresis association registry, 2023 update.
Transfus Apher Sci
December 2023
Department of Clinical Microbiology, Division of Clinical Immunology, Umeå University, Umeå, Sweden.
The WAA apheresis registry contains data on more than 140,000 apheresis procedures conducted in 12 different countries. The aim is to give an update of indications, type and number of procedures and adverse events (AEs). MATERIAL AND METHODS: The WAA-registry is used for registration of apheresis procedures and is free of charge.
View Article and Find Full Text PDFAnalysis of first apheresis services in Ghana-Greater Accra Regional Hospital.
Heliyon
November 2022
Medical Directorate, Greater Accra Regional Hospital (GARH), Accra, Ghana.
Background: At the combined American Society for Apheresis (ASFA) annual meeting and World Apheresis Association (WAA) Congress in 2014, it was observed that there were significant disparities with regard to the access of apheresis services within and across developing countries, with only few of such facilities available in Africa; notably South Africa and Nigeria. In 2019, Bone Marrow Transplantation (BMT) Unit-Ghana, acquired an apheresis machine. By the collaboration between BMT-Ghana, the Greater Accra Regional Hospital (GARH) and the Ministry of Health (Ghana), apheresis services is now available in Ghana.
View Article and Find Full Text PDFBackground: In a Phase I study treatment with the serum amyloid P component (SAP) depleter miridesap followed by monoclonal antibody to SAP (dezamizumab) showed removal of amyloid from liver, spleen and kidney in patients with systemic amyloidosis. We report results from a Phase 2 study and concurrent immuno-positron emission tomography (PET) study assessing efficacy, pharmacodynamics, pharmacokinetics, safety and cardiac uptake (of dezamizumab) following the same intervention in patients with cardiac amyloidosis.
Methods: Both were uncontrolled open-label studies.
Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis.
Transfus Med Hemother
August 2021
South African National Blood Service, Johannesburg, South Africa.
Article Synopsis
- Therapeutic apheresis (TA) is a special treatment for patients with serious illnesses that don't get better with regular medicine.
- Researchers gathered data from over 104,000 TA procedures on more than 15,000 patients to learn more about its effects and outcomes.
- Most patients needed it to collect stem cells for treatment, and the number of side effects has gone down a lot in recent years, showing that the treatment is becoming safer.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!